National Quality Assessment Evaluating Spironolactone Use During Hospitalization for Acute Myocardial Infarction (AMI) in China: China Patient-centered Evaluation Assessment of Cardiac Events (PEACE)-Retrospective AMI Study, 2001, 2006, and 2011

BACKGROUND: Spironolactone, the only aldosterone antagonist available in China, improves outcomes in acute myocardial infarction (AMI) among patients with systolic dysfunction and either diabetes or heart failure (HF). However, national practice patterns in the use of spironolactone in China are unk...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Heart Assoc
Auteurs principaux: Guan, Wenchi, Murugiah, Karthik, Downing, Nicholas, Li, Jing, Wang, Qing, Ross, Joseph S, Desai, Nihar R, Masoudi, Frederick A, Spertus, John A, Li, Xi, Krumholz, Harlan M, Jiang, Lixin
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2015
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599529/
https://ncbi.nlm.nih.gov/pubmed/26071031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.114.001718
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires